← Back to search

Protein Structures and Oligomeric States

Enter a protein name, UniProt accession or PDB ID. Name searches ask you to confirm the protein identity before related structures are queried.

Current Protein Identity：A8K1V4 New Search
37PDB entries
66Biological assembly
66chain/assembly records
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
3P88 FXR bound to isoquinolinecarboxylic acid Deposited 2010-10-13 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 745–755（11 aa） Fragment：unp residues 745-755
Not recorded P88 7-(4-{[3-(2,6-dimethylphenyl)-5-(1-methylethyl)isoxazol-4-yl]methoxy}phenyl)isoquinoline-3-carboxylic acid × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；295 K；peg3350 22%, Hepes, 0.2 M Li2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.95 Å R-free 0.289
3P88 FXR bound to isoquinolinecarboxylic acid Deposited 2010-10-13 Assembly 2 Protein heterocomplex Heteromer；Protein × 24 PDB declaration: 24-meric（24） Consistent with protein count
Chain B 745–755（11 aa） Fragment：unp residues 745-755
Not recorded P88 7-(4-{[3-(2,6-dimethylphenyl)-5-(1-methylethyl)isoxazol-4-yl]methoxy}phenyl)isoquinoline-3-carboxylic acid × 12 SO4 SULFATE ION × 12 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；295 K；peg3350 22%, Hepes, 0.2 M Li2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.95 Å R-free 0.289
3P88 FXR bound to isoquinolinecarboxylic acid Deposited 2010-10-13 Assembly 3 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count
Chain B 745–755（11 aa） Fragment：unp residues 745-755
Not recorded P88 7-(4-{[3-(2,6-dimethylphenyl)-5-(1-methylethyl)isoxazol-4-yl]methoxy}phenyl)isoquinoline-3-carboxylic acid × 3 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；295 K；peg3350 22%, Hepes, 0.2 M Li2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.95 Å R-free 0.289
3P89 FXR bound to a quinolinecarboxylic acid Deposited 2010-10-13 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 745–755（11 aa） Fragment：unp residues 745-755
Not recorded 89P 6-(4-{[3-(2,6-dichlorophenyl)-5-(1-methylethyl)isoxazol-4-yl]methoxy}phenyl)quinoline-2-carboxylic acid × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；295 K；peg3350 20%, .2 M Li2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.30 Å R-free 0.255
3P89 FXR bound to a quinolinecarboxylic acid Deposited 2010-10-13 Assembly 2 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count
Chain B 745–755（11 aa） Fragment：unp residues 745-755
Not recorded 89P 6-(4-{[3-(2,6-dichlorophenyl)-5-(1-methylethyl)isoxazol-4-yl]methoxy}phenyl)quinoline-2-carboxylic acid × 3 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；295 K；peg3350 20%, .2 M Li2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.30 Å R-free 0.255
3P89 FXR bound to a quinolinecarboxylic acid Deposited 2010-10-13 Assembly 3 Protein heterocomplex Heteromer；Protein × 24 PDB declaration: 24-meric（24） Consistent with protein count
Chain B 745–755（11 aa） Fragment：unp residues 745-755
Not recorded 89P 6-(4-{[3-(2,6-dichlorophenyl)-5-(1-methylethyl)isoxazol-4-yl]methoxy}phenyl)quinoline-2-carboxylic acid × 12 SO4 SULFATE ION × 12 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；295 K；peg3350 20%, .2 M Li2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.30 Å R-free 0.255
5Q0J Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9KV (2S)-N,2-dicyclohexyl-2-[2-(5-phenylthiophen-2-yl)-1H-benzimidazol-1-yl]acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.2 M Na Chloride, 0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 2.00 Å R-free 0.247
5Q0J Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9KV (2S)-N,2-dicyclohexyl-2-[2-(5-phenylthiophen-2-yl)-1H-benzimidazol-1-yl]acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.2 M Na Chloride, 0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 2.00 Å R-free 0.247
5Q0K Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 7.5；298 K；0.2M MgCl2, 0.1M HEPES pH 7.5, 25%PEG3350
Resolution 1.80 Å R-free 0.271
5Q0L Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9KY (2S)-N,2-dicyclohexyl-2-{2-[4-(hydroxymethyl)phenyl]-1H-benzimidazol-1-yl}acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 2.50 Å R-free 0.263
5Q0L Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9KY (2S)-N,2-dicyclohexyl-2-{2-[4-(hydroxymethyl)phenyl]-1H-benzimidazol-1-yl}acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 2.50 Å R-free 0.263
5Q0M Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9L1 5-{[(3beta,5beta,14beta,17alpha)-3-hydroxy-24-oxocholan-24-yl]amino}benzene-1,3-dicarboxylic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 7.5；298 K；0.1 M HEPES pH 7.5, 1.4 M Sodium Citrate
Resolution 2.20 Å R-free 0.262
5Q0N Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9L4 3-chloro-4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)benzoic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 7.5；298 K；0.2 M Mg Chloride, 0.1 M HEPES pH 7.5, 25% w/v PEG 3350
Resolution 2.40 Å R-free 0.226
5Q0N Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9L4 3-chloro-4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)benzoic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 7.5；298 K；0.2 M Mg Chloride, 0.1 M HEPES pH 7.5, 25% w/v PEG 3350
Resolution 2.40 Å R-free 0.226
5Q0O Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded CL CHLORIDE ION × 1 9L7 (2S)-2-{2-[4-(benzenecarbonyl)phenyl]-1H-benzimidazol-1-yl}-N,2-dicyclohexylacetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.2M NaCl, 0.1M Bis-Tris pH 6.5, 25% PEG3350
Resolution 1.90 Å R-free 0.222
5Q0O Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9L7 (2S)-2-{2-[4-(benzenecarbonyl)phenyl]-1H-benzimidazol-1-yl}-N,2-dicyclohexylacetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.2M NaCl, 0.1M Bis-Tris pH 6.5, 25% PEG3350
Resolution 1.90 Å R-free 0.222
5Q0P Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LA 4-{(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylethoxy}benzoic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 5.5；298 K；0.1M Bis-Tris pH 5.5, 2M Ammonium Sulfate
Resolution 1.80 Å R-free 0.254
5Q0P Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LA 4-{(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylethoxy}benzoic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 5.5；298 K；0.1M Bis-Tris pH 5.5, 2M Ammonium Sulfate
Resolution 1.80 Å R-free 0.254
5Q0Q Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LD ethyl 4-({2-phenyl-5-[(thiophen-2-yl)sulfonyl]-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-3-carbonyl}amino)benzoate × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 7.5；298 K；0.1 M HEPES pH 7.5, 2.0 M Ammonium Sulfate
Resolution 2.60 Å R-free 0.295
5Q0Q Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LD ethyl 4-({2-phenyl-5-[(thiophen-2-yl)sulfonyl]-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-3-carbonyl}amino)benzoate × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 7.5；298 K；0.1 M HEPES pH 7.5, 2.0 M Ammonium Sulfate
Resolution 2.60 Å R-free 0.295
5Q0R Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LG N,1-dibenzyl-6-[(2-fluorophenyl)sulfonyl]-4,5,6,7-tetrahydro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.2 M Mg Chloride, 0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 1.91 Å R-free 0.244
5Q0S Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LJ (2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-N-(2-cyanophenyl)-2-cyclohexylacetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 28% w/v PEG MME 2000
Resolution 2.50 Å R-free 0.260
5Q0S Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LJ (2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-N-(2-cyanophenyl)-2-cyclohexylacetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 28% w/v PEG MME 2000
Resolution 2.50 Å R-free 0.260
5Q0T Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LM 2-phenyl-N-(propan-2-yl)-6-[(thiophen-2-yl)sulfonyl]-4,5,6,7-tetrahydro-1H-pyrrolo[2,3-c]pyridine-1-carboxamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 7；298 K；3.5 M Sodium Formate pH 7.0
Resolution 2.14 Å R-free 0.259
5Q0U Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LP trans-4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)cyclohexyl hydrogen sulfate × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 28% w/v PEG MME 2000
Resolution 1.90 Å R-free 0.218
5Q0U Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LP trans-4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)cyclohexyl hydrogen sulfate × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 28% w/v PEG MME 2000
Resolution 1.90 Å R-free 0.218
5Q0V Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LS (2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexyl-N-(2-fluorophenyl)acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 1.87 Å R-free 0.238
5Q0V Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LS (2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexyl-N-(2-fluorophenyl)acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 1.87 Å R-free 0.238
5Q0W Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa）
Not recorded 9LV 4-({5-bromo-1'-[(2-chlorophenyl)sulfonyl]-2-oxospiro[indole-3,4'-piperidin]-1(2H)-yl}methyl)benzoic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 8.5；298 K；0.2M MgCl2, 0.1M Tris pH 8.5, 25%PEG3350
Resolution 1.90 Å R-free 0.254
5Q0X Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 643 6-(4-{[3-(3,5-dichloropyridin-4-yl)-5-(1-methylethyl)isoxazol-4-yl]methoxy}-2-methylphenyl)-1-methyl-1H-indole-3-carbox ylic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.2 M Mg Chloride, 0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 2.26 Å R-free 0.233
5Q0Y Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LY (2S)-N,2-dicyclohexyl-2-{5,6-difluoro-2-[6-(1H-pyrazol-1-yl)pyridin-3-yl]-1H-benzimidazol-1-yl}acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；298 K；25% w/v PEG 1500
Resolution 2.20 Å R-free 0.220
5Q0Y Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9LY (2S)-N,2-dicyclohexyl-2-{5,6-difluoro-2-[6-(1H-pyrazol-1-yl)pyridin-3-yl]-1H-benzimidazol-1-yl}acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；298 K；25% w/v PEG 1500
Resolution 2.20 Å R-free 0.220
5Q0Z Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9M1 ethyl (5S)-3-(3,4-difluorobenzene-1-carbonyl)-1,1-dimethyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole-5-carboxylate × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6；298 K；0.1 M Bis-Tris pH 6.0, 20% w/v PEG 3350
Resolution 2.26 Å R-free 0.258
5Q0Z Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9M1 ethyl (5S)-3-(3,4-difluorobenzene-1-carbonyl)-1,1-dimethyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole-5-carboxylate × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6；298 K；0.1 M Bis-Tris pH 6.0, 20% w/v PEG 3350
Resolution 2.26 Å R-free 0.258
5Q10 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9M4 N-[3-(acetylamino)phenyl]-4-chloro-N-[(1S)-1-cyclohexyl-2-(cyclohexylamino)-2-oxoethyl]benzamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 8.5；298 K；0.2M MgCl2, 0.1M Tris pH 8.5, 25%PEG3350
Resolution 2.20 Å R-free 0.243
5Q11 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9M7 N,N-dicyclohexyl-3-(2,4-dichlorophenyl)-5-methyl-1,2-oxazole-4-carboxamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1M Bis-Tris pH 6.5, 2M Ammonium Sulfate
Resolution 2.20 Å R-free 0.223
5Q12 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9MA 2-(2,6-difluorophenyl)-N-(2,6-dimethylphenyl)-5-methylimidazo[1,2-a]pyridin-3-amine × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 8.5；298 K；0.2 M Li Sulfate, 0.1 M Tris pH 8.5, 25% w/v PEG 3350
Resolution 2.00 Å R-free 0.233
5Q13 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9MD (2S)-2-[6-chloro-2-(4-chlorophenyl)-5-fluoro-1H-benzimidazol-1-yl]-N-cyclohexyl-2-[(2S)-oxan-2-yl]acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 1.90 Å R-free 0.226
5Q13 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9MD (2S)-2-[6-chloro-2-(4-chlorophenyl)-5-fluoro-1H-benzimidazol-1-yl]-N-cyclohexyl-2-[(2S)-oxan-2-yl]acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 1.90 Å R-free 0.226
5Q14 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9MM 4-{(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylethoxy}-3-fluorobenzoic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.2 M Ammonium Acetate, 0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 1.85 Å R-free 0.247
5Q14 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9MM 4-{(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylethoxy}-3-fluorobenzoic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.2 M Ammonium Acetate, 0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 1.85 Å R-free 0.247
5Q15 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9MP (2S)-N,2-dicyclohexyl-2-{5,6-difluoro-2-[(R)-methoxy(phenyl)methyl]-1H-benzimidazol-1-yl}acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 3.5；298 K；0.1 M Citric Acid pH 3.5, 3.0 M Sodium Chloride
Resolution 1.90 Å R-free 0.255
5Q15 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9MP (2S)-N,2-dicyclohexyl-2-{5,6-difluoro-2-[(R)-methoxy(phenyl)methyl]-1H-benzimidazol-1-yl}acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 3.5；298 K；0.1 M Citric Acid pH 3.5, 3.0 M Sodium Chloride
Resolution 1.90 Å R-free 0.255
5Q16 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9MS (2S)-2-{2-[(4-chloro-2-methylphenoxy)methyl]-6-fluoro-1H-benzimidazol-1-yl}-N,2-dicyclohexylacetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 28% w/v PEG MME 2000
Resolution 2.00 Å R-free 0.284
5Q16 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9MS (2S)-2-{2-[(4-chloro-2-methylphenoxy)methyl]-6-fluoro-1H-benzimidazol-1-yl}-N,2-dicyclohexylacetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 28% w/v PEG MME 2000
Resolution 2.00 Å R-free 0.284
5Q18 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9MY (2S)-2-cyclohexyl-2-{5,6-difluoro-2-[(R)-methoxy(phenyl)methyl]-1H-benzimidazol-1-yl}-N-(trans-4-hydroxycyclohexyl)acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 1.90 Å R-free 0.240
5Q18 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9MY (2S)-2-cyclohexyl-2-{5,6-difluoro-2-[(R)-methoxy(phenyl)methyl]-1H-benzimidazol-1-yl}-N-(trans-4-hydroxycyclohexyl)acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 1.90 Å R-free 0.240
5Q19 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9N1 (2S)-N,2-dicyclohexyl-2-[2-(2,4-dimethoxyphenyl)-1H-benzimidazol-1-yl]acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 24% w/v PEG 3350
Resolution 1.98 Å R-free 0.237
5Q19 Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9N1 (2S)-N,2-dicyclohexyl-2-[2-(2,4-dimethoxyphenyl)-1H-benzimidazol-1-yl]acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 24% w/v PEG 3350
Resolution 1.98 Å R-free 0.237
5Q1A Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9N4 (2S)-2-cyclohexyl-2-[2-(2,4-dimethoxyphenyl)-1H-benzimidazol-1-yl]-N-(2,6-dimethylphenyl)acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 20% w/v PEG MME 5000
Resolution 2.00 Å R-free 0.235
5Q1A Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9N4 (2S)-2-cyclohexyl-2-[2-(2,4-dimethoxyphenyl)-1H-benzimidazol-1-yl]-N-(2,6-dimethylphenyl)acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 20% w/v PEG MME 5000
Resolution 2.00 Å R-free 0.235
5Q1B Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9N7 4-{[(2S)-2-cyclohexyl-2-{5,6-difluoro-2-[4-(1,3-thiazol-2-yl)phenyl]-1H-benzimidazol-1-yl}acetyl]amino}benzoic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 28% w/v PEG MME 2000
Resolution 2.30 Å R-free 0.236
5Q1B Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9N7 4-{[(2S)-2-cyclohexyl-2-{5,6-difluoro-2-[4-(1,3-thiazol-2-yl)phenyl]-1H-benzimidazol-1-yl}acetyl]amino}benzoic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 28% w/v PEG MME 2000
Resolution 2.30 Å R-free 0.236
5Q1C Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9NA (2S)-2-cyclohexyl-2-[2-(2,6-dimethoxypyridin-3-yl)-5,6-difluoro-1H-benzimidazol-1-yl]-N-(trans-4-hydroxycyclohexyl)acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 7.5；298 K；0.2 M Ammonium Sulfate, 0.1 M HEPES pH 7.5, 25% w/v PEG 3350
Resolution 2.30 Å R-free 0.264
5Q1C Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9NA (2S)-2-cyclohexyl-2-[2-(2,6-dimethoxypyridin-3-yl)-5,6-difluoro-1H-benzimidazol-1-yl]-N-(trans-4-hydroxycyclohexyl)acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 7.5；298 K；0.2 M Ammonium Sulfate, 0.1 M HEPES pH 7.5, 25% w/v PEG 3350
Resolution 2.30 Å R-free 0.264
5Q1D Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9ND (2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexyl-N-phenylacetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.2 M Na Chloride, 0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 1.89 Å R-free 0.244
5Q1D Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9ND (2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexyl-N-phenylacetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.2 M Na Chloride, 0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 1.89 Å R-free 0.244
5Q1E Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9NG 5-bromo-1-{[4-(1H-tetrazol-5-yl)phenyl]methyl}-1'-(thiophene-2-sulfonyl)spiro[indole-3,4'-piperidin]-2(1H)-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 7.5；298 K；0.2M MgCl2, 0.1M HEPES pH 7.5, 25%PEG3350
Resolution 1.85 Å R-free 0.223
5Q1F Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9NJ trans-4-({(2S)-2-cyclohexyl-2-[2-(2,6-dimethoxypyridin-3-yl)-5-fluoro-1H-benzimidazol-1-yl]acetyl}amino)cyclohexane-1-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 2.30 Å R-free 0.245
5Q1F Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9NJ trans-4-({(2S)-2-cyclohexyl-2-[2-(2,6-dimethoxypyridin-3-yl)-5-fluoro-1H-benzimidazol-1-yl]acetyl}amino)cyclohexane-1-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 2.30 Å R-free 0.245
5Q1G Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9NM (2E)-N-cyclohexyl-N-(cyclohexylcarbamoyl)-3-(4-fluorophenyl)prop-2-enamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.1M Bis-Tris pH 6.5, 2M Ammonium Sulfate
Resolution 2.00 Å R-free 0.254
5Q1H Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9NP (2S)-N,2-dicyclohexyl-2-{2-[4-(1H-tetrazol-5-yl)phenyl]-1H-benzimidazol-1-yl}acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 5.5；298 K；0.1 M BIS-TRIS pH 5.5, 25%PEG3350
Resolution 2.20 Å R-free 0.218
5Q1H Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain D 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9NP (2S)-N,2-dicyclohexyl-2-{2-[4-(1H-tetrazol-5-yl)phenyl]-1H-benzimidazol-1-yl}acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 5.5；298 K；0.1 M BIS-TRIS pH 5.5, 25%PEG3350
Resolution 2.20 Å R-free 0.218
5Q1H Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 3 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain F 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9NP (2S)-N,2-dicyclohexyl-2-{2-[4-(1H-tetrazol-5-yl)phenyl]-1H-benzimidazol-1-yl}acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 5.5；298 K；0.1 M BIS-TRIS pH 5.5, 25%PEG3350
Resolution 2.20 Å R-free 0.218
5Q1H Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 4 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain H 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9NP (2S)-N,2-dicyclohexyl-2-{2-[4-(1H-tetrazol-5-yl)phenyl]-1H-benzimidazol-1-yl}acetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 5.5；298 K；0.1 M BIS-TRIS pH 5.5, 25%PEG3350
Resolution 2.20 Å R-free 0.218
5Q1I Ligand binding to FARNESOID-X-RECEPTOR Deposited 2017-05-31 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain B 744–757（14 aa） Fragment：UNP residues 744-757
Not recorded 9O1 3-(2-chlorophenyl)-N-[(1R)-1-(naphthalen-2-yl)ethyl]-5-(propan-2-yl)-1,2-oxazole-4-carboxamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions evaporation, hanging drop；pH 6.5；298 K；0.2 M Mg Chloride, 0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350
Resolution 1.95 Å R-free 0.225

This page presents structural evidence recorded in PDB/mmCIF.“No recorded non-water small molecule” does not prove that the experimental sample was ligand-free; experimental conditions belong to the PDB experiment, while ligands and copy counts are shown for each biological assembly.